US2022313598A1PendingUtilityA1
Antimicrobial Compositions and Methods For Reducing Microbial Contamination
Est. expiryMay 6, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61K 8/11A01N 25/02A01N 47/44A61K 47/32A01N 33/12A01N 25/10A61K 8/416A61K 2800/56A61Q 17/00A01N 39/00A61K 8/90A61K 9/0014A61Q 17/005
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the fields of microbiology and health care, in particular to means and methods for minimizing the spread of hospital-acquired (HA) infections e.g. between patients and healthcare workers. Provided is an antimicrobial composition comprising an antimicrobial agent, a pharmaceutically acceptable carrier material and a polymer, the polymer being an N-vinyl lactam copolymer, and the composition being capable of forming a slow release antimicrobial film when applied to a skin surface.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An antimicrobial composition comprising an antimicrobial agent, a pharmaceutically acceptable carrier material, and an N-vinyl lactam copolymer, wherein said copolymer is obtainable by solution polymerization of vinyl pyrrolidone monomer units (A) and hydrophobically derivatized maleate monomer units (B) of the following general formula:
Wherein
R 1 and R 2 are each independently hydrogen or methyl,
R 3 and R 4 are each independently selected from hydrogen, and linear and branched C6-C20 alkyl groups, with the exception that both R 3 and R 4 are hydrogen,
wherein said polymerization comprises the continuously feeding of a monomer mixture comprising about 70-90 weight % of monomer (A) and about 10-30 weight % of monomer (B), over a predetermined period of time to the reaction mixture.
2 . The antimicrobial composition according to claim 1 , wherein said monomer mixture comprises 75-90 weight %, of monomer (A) and about 10-25 weight % of monomer (B).
3 . The antimicrobial composition according to claim 1 , wherein R 3 and R 4 are each independently selected from hydrogen, linear and branched C6-C12 alkyl groups.
4 . The antimicrobial composition according to claim 1 , wherein R 3 and R 4 are each independently selected from hydrogen, linear and branched C10-C20 alkyl groups.
5 . The antimicrobial composition according to claim 1 , wherein both R 3 and R 4 are linear C8-C14 alkyl.
6 . The antimicrobial composition according to claim 1 , wherein R 3 and R 4 are each independently selected from hydrogen and branched C16-C20 alkyl groups.
7 . The antimicrobial composition according to claim 1 , wherein R 3 or R 4 is hydrogen.
8 . The antimicrobial composition according to claim 1 , wherein R 3 and R 4 are the same.
9 . The antimicrobial composition according to claim 1 , wherein the N-vinyl lactam copolymer is present in said composition at a concentration of about 0.5-10 weight percent.
10 . The antimicrobial composition according to claim 1 , wherein the concentration of antimicrobial agent is between about 0.01 and 2 weight percent.
11 . The antimicrobial composition according to claim 1 , wherein said antimicrobial agent is selected from the group consisting of quaternium salts, phenols, halogen-releasing compounds, aldehydes, biguanides and polymeric biguanides, amphoterics, iodine-based compounds, peroxygen-based compounds, and silver-containing compounds.
12 . The antimicrobial composition according to claim 11 , wherein the antimicrobial agent is a quaternary ammonium compound selected from the group consisting of benzethonium chloride, benzalkonium or benzethonium bromide or fluoride, cetyl pyridinium chloride, dequalinium chloride, N-myristyl-N-methyl-morpholinium methyl sulfate, poly[N-[3-(dimethylammonio)propyl]-N′-[3-(ethyleneoxyethelene dimethylammonio)propyl]urea dichloride], alpha-4-[1-tris(2-hydroxyethyl)ammonium chloride-2-butenyl]-omega-tris(2-hydroxyethyl)ammonium chloride, and poly[oxyethylene (dimethyliminio)ethylene (dimethyliminio)-ethylene dichloride].
13 . The antimicrobial composition according to claim 1 , wherein the pharmaceutically acceptable carrier material is an alcohol, water, an ester, a skin care oil, an emulsifier, emollient, or any mixture thereof.
14 . A method for reducing or eliminating the number of micro-organisms on a surface, comprising applying an antimicrobial composition according to claim 1 to said surface and allowing the formation of an antimicrobial film.
15 . The method according to claim 14 , wherein said surface is the surface of skin, hair and/or nails, or wherein the surface is the surface of a medical device or a personal care product.
16 . The method according to claim 14 , wherein said micro-organisms are bacteria, viruses, fungi, spores or yeast.
17 . A product comprising a composition according to claim 1 , the product selected from a skin sanitizer, hand-rub, or (micro)glove.
18 . A slow-release carrier for an antimicrobial agent in an antimicrobial film or coating comprising N-vinyl lactam copolymer,
wherein said copolymer is obtainable by solution polymerization of vinyl pyrrolidone monomer units (A) and hydrophobically derivatized maleate monomer units (B) wherein (B) is defined according to the following general formula:
R1 and R2 are each independently hydrogen or methyl,
R3 and R4 are each independently selected from hydrogen, linear and branched C6-C20 alkyl groups, with the exception that both R3 and R4 are hydrogen,
wherein said polymerization comprises the continuously feeding of a monomer mixture comprising about 70-90 weight % of monomer (A) and about 10-30 weight % of monomer (B), over a predetermined period of time to the reaction mixture.Join the waitlist — get patent alerts
Track US2022313598A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.